Study in Patients With Asthma
This study has been completed.
Information provided by:
First received: September 13, 2005
Last updated: November 10, 2010
Last verified: February 2008
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Dey:
Primary Outcome Measures:
- Measure of lung function.
Secondary Outcome Measures:
- Change in lung function, vital signs, physical examinations, clinical laboratory assessments, and adverse event reporting.
|Study Start Date:||July 2002|
|Study Completion Date:||December 2005|
|Primary Completion Date:||October 2002 (Final data collection date for primary outcome measure)|
Contacts and Locations